(Q41104653)
Statements
Chimeric CLL-1 antibody fusion proteins containing granulocyte-macrophage colony-stimulating factor or interleukin-2 with specificity for B-cell malignancies exhibit enhanced effector functions while retaining tumor targeting properties (English)
Hornick JL
Khawli LA
Hu P
Lynch M
Anderson PM